OBJECTIVE
To determine which serotoninergic receptor subtype(s) mediates the regional vasodilator response to scald injury.
DESIGN
Prospective, randomized trial.
SETTING
Microcirculation research laboratory.
SUBJECTS
Anesthetized dogs.
INTERVENTIONS
Mechanically ventilated dogs underwent cannulation of a brachial artery and placement of an ultrasonic flow probe around one femoral artery. All animals received a 2% to 3% body surface area partial thickness scald injury by immersing the paw ipsilateral to the instrumented femoral artery into 100 degrees C water for 5 secs. In one group of dogs, BMY 7378 (a serotoninergic1A receptor antagonist) was given by the peripheral intravenous route before burn. These results were compared with those findings obtained from a group of animals that received a burn only, and groups of animals given a peripheral intravenous injection of methysergide (a serotoninergic receptor antagonist) or ritanserin (a serotoninergic2 receptor blocking agent) before burn. Experiments were conducted for two postburn hours.
MEASUREMENTS AND MAIN RESULTS
Burn injury caused a marked and persistent increase in regional (e.g., femoral artery) blood flow, an effect that was significantly blunted by preburn administration of the serotoninergic receptor antagonist, methysergide. Preburn administration of BMY 7378 increased baseline femoral blood flow by 13%, reflecting its known serotonin agonist properties. However, when compared with the mean postscald increases in femoral blood flow over baseline seen in scald only dogs and in animals given the serotoninergic2 receptor blocking agent, ritanserin (before scald), the BMY 7378-treated group demonstrated a significant (p < .001 by analysis of variance) 2-hr-postscald blunting of this femoral vasodilator response.
CONCLUSION
These data suggest that serotoninergic1A-like receptors play an integral, albeit not an exclusive, role in blood flow regulation to the site of burn injury.
[1]
M. Erlander,et al.
Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.
,
1993,
Proceedings of the National Academy of Sciences of the United States of America.
[2]
J. Greuel,et al.
The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro.
,
1992,
European journal of pharmacology.
[3]
R. Barrow,et al.
Propranolol diminishes extremity blood flow in burned patients.
,
1991,
Annals of surgery.
[4]
S. Peroutka.
5-Hydroxytryptamine receptor subtypes.
,
1990,
Pharmacology & toxicology.
[5]
K. Proctor,et al.
Modulation of arteriolar blood flow by inhibitors of arachidonic acid oxidation after thermal injury: possible role for a novel class of vasodilator metabolites.
,
1988,
Circulation.
[6]
E. Boddeke,et al.
Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in‐vivo α1‐, α2‐ and 5‐HT2‐receptor antagonism and in‐vitro affinity for α1‐, α2‐ and 5‐HT2‐receptors: comparison with ketanserin
,
1986
.
[7]
C. Valeri,et al.
Arachidonic acid metabolites mediate early burn edema.
,
1984,
The Journal of trauma.
[8]
W. Baze,et al.
Control of Blood Flow in a Large Surface Wound
,
1980,
Annals of surgery.
[9]
A. Mason,et al.
Influence of the Burn Wound on Local and Systemic Responses to Injury
,
1977,
Annals of surgery.